Toriola

Breast cancer rates increasing among younger women medicine.wustl.edu/news/breast-ca… via @wustlmed

Breast cancer rates are rising faster in younger than older women — with multiple possible factors involved. @WashUMedicine researcher @TJToriola, PhD, and others share their perspectives with NBC News. nbcnews.com/health/womens-…

More young women are getting breast cancer — why? Dr. Toriola explains some of the factors driving the increase in women’s breast cancer diagnoses among women under 50. source.washu.edu/2025/06/more-y…

We're honored that @Newsweek has recognized Siteman as the No. 1 cancer center in Missouri and Illinois — and among the best of the best nationally. siteman.wustl.edu/newsweek-names…

⁦Impactful work on proteomics of MBD led and presented by the brilliant Dr. Pourali - ⁦@Pourali_G⁩ ⁦@WashUpubhealth⁩ ⁦@SitemanCenter⁩

Making Time jamanetwork.com/journals/jamao…

Breast cancer rates are climbing for women under 50. Washington University researchers Graham Colditz, MD, DrPH, and Adetunji Toriola, MD, PhD, at Siteman Cancer Center, shed light on key risk factors. Read more in The New York Times: nyti.ms/4gVXlTd @washumedicine @WashUPhysicians @nytimes

More young women are being diagnosed with breast cancer. NBC News spoke with @TJToriola, a @WashUmedicine molecular epidemiologist at Siteman, about research into the reasons why.   nbcnews.com/health/womens-…

Honored to contribute to this @NBCNewsHealth @NBCNews article along with some incredible people in the field - @AnnPartridgeMD, @TJToriola and @A_THOMASMD. #BreastCancer #bcsm Thank you @marinakopf and @kaitsulliva for this important article! nbcnews.com/health/womens-…

Breast cancer is the 2nd most common cancer in women. This #BreastCancerAwarenessMonth, join @theNCI's Dr. Brandy Heckman-Stoddard on #EmpathyAffect #podcast to learn about prevention breakthroughs like vaccines and gels for risk reduction. Listen now: bit.ly/3TSmB3e

#ICYMI...NEW RESEARCH: PFAS Levels, Early Life Factors, and Mammographic Breast Density in Premenopausal Women ➡️ buff.ly/4e7aO9j @WUSTLmed @WUSTLphs @WashUSurgery @TJToriola @SitemanCenter

Menopausal hormone therapy use declined among postmenopausal women in the US from 1999 to 2020, with significant variations in patterns of use and correlates across age and racial/ethnic groups according to this cross-sectional study. ja.ma/3XUOGtb

NEW RESEARCH: PFAS Levels, Early Life Factors, and Mammographic Breast Density in Premenopausal Women ➡️ buff.ly/4e7aO9j @WUSTLmed @WUSTLphs @WashUSurgery @TJToriola @SitemanCenter

@NeliMUlrich @huntsmancancer @UUtah Congratulations Neli!

Panelists to explore new and emerging advances in precision chemoprevention aacrmeetingnews.org/news/panelists… Looking forward to engaging discussions

Wednesday morning at #AACR24: Panelists will explore new and emerging advances in precision chemoprevention. Read a preview in AACR Annual Meeting News: bit.ly/3VTisOp @TJToriola

Breast cancer incidence rates among women aged 20-49 is increasing, driven by increases in ER+ tumors. Prevention efforts in young women need to adopt a targeted approach to address racial disparities in incidence rates. ja.ma/4b97yJF

Honored to see our article on the lipidome of mammographic breast density in premenopausal women: rdcu.be/dvYFf featured as one NCI Epidemiology and Genomics Research Program 2023 Research Highlights @WUSTLphs @SitemanCenter @WashUSurgery. See epi.grants.cancer.gov/research-highl…

@Cheng15 @Cheng15. I enjoyed my visit and our conversations on how to translate molecular epidemiology studies of breast cancer to prevention.

@TJToriola Thank you for visiting!!

Dr. Adetunji Toriola on Translating evidence to breast cancer prevention. Molecular Epidemiology WG @OSUCCC_James